COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medicine, Market Insights and Forecast to 2026
Radiopharmaceuticals in Nuclear Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Radiopharmaceuticals in Nuclear Medicine market is segmented into
The Radiopharmaceuticals in Nuclear Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiopharmaceuticals in Nuclear Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
Radiopharmaceuticals in Nuclear Medicine market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceuticals in Nuclear Medicine business, the date to enter into the Radiopharmaceuticals in Nuclear Medicine market, Radiopharmaceuticals in Nuclear Medicine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Radiopharmaceuticals in Nuclear Medicine market is segmented into
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Other
The Radiopharmaceuticals in Nuclear Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiopharmaceuticals in Nuclear Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
Radiopharmaceuticals in Nuclear Medicine market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceuticals in Nuclear Medicine business, the date to enter into the Radiopharmaceuticals in Nuclear Medicine market, Radiopharmaceuticals in Nuclear Medicine product introduction, recent developments, etc.
The major vendors covered:
- Bracco Imaging S.P.A.
- Cambridge Isotope Laboratories, Inc.
- Cardinal Health, Inc.
- Covidien, Plc
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Isotec, Inc. (Sigma-Aldrich)
- Lantheus Medical Imaging, Inc.
- Nordion, Inc.
- Ntp Radioisotopes (Pty), Ltd.
- Siemens Healthcare (Subsidiary Of Siemens AG)
- Taiyo Nippon Sanso Corporation
- Urenco Limited
- Rotem Industries, Ltd., Inc.
- Australian Nuclear Association And Technology Organization (ANSTO)
- Board of Radiation And Isotope Technology (BRIT)
- Institute of Atomic Energy Polatom Radioisotope Centre
- Institute of Isotopes Co., Ltd.
- Institute Of Radioelement (IRE)
1 STUDY COVERAGE
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market Segments
1.3 Key Radiopharmaceuticals in Nuclear Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medicine Industry
1.6.1.1 Radiopharmaceuticals in Nuclear Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2015-2026
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026
2.2 Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020)
3.1.2 Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2019
3.2.5 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (2015-2020)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020)
4.1.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (2015-2020)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2015-2020)
5.1.3 Radiopharmaceuticals in Nuclear Medicine Price by Application (2015-2020)
5.2 Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Radiopharmaceuticals in Nuclear Medicine by Country
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
6.3 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Country
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Region
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Radiopharmaceuticals in Nuclear Medicine by Country
9.1.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
9.1.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
9.3 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Country
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
11.2.2 Cambridge Isotope Laboratories, Inc. Description, Business Overview and Total Revenue
11.2.3 Cambridge Isotope Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Corporation Information
11.3.2 Cardinal Health, Inc. Description, Business Overview and Total Revenue
11.3.3 Cardinal Health, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.3.5 Cardinal Health, Inc. Recent Development
11.4 Covidien, Plc
11.4.1 Covidien, Plc Corporation Information
11.4.2 Covidien, Plc Description, Business Overview and Total Revenue
11.4.3 Covidien, Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
11.4.5 Covidien, Plc Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Corporation Information
11.5.2 Eczacibasi-Monrol Description, Business Overview and Total Revenue
11.5.3 Eczacibasi-Monrol Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Corporation Information
11.6.2 Fujifilm Holdings Corporation Description, Business Overview and Total Revenue
11.6.3 Fujifilm Holdings Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Description, Business Overview and Total Revenue
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Corporation Information
11.8.2 IBA Group Description, Business Overview and Total Revenue
11.8.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
11.8.5 IBA Group Recent Development
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
11.9.2 Isotec, Inc. (Sigma-Aldrich) Description, Business Overview and Total Revenue
11.9.3 Isotec, Inc. (Sigma-Aldrich) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Corporation Information
11.10.2 Lantheus Medical Imaging, Inc. Description, Business Overview and Total Revenue
11.10.3 Lantheus Medical Imaging, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.10.5 Lantheus Medical Imaging, Inc. Recent Development
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.12 Ntp Radioisotopes (Pty), Ltd.
11.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
11.12.2 Ntp Radioisotopes (Pty), Ltd. Description, Business Overview and Total Revenue
11.12.3 Ntp Radioisotopes (Pty), Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ntp Radioisotopes (Pty), Ltd. Products Offered
11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Description, Business Overview and Total Revenue
11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Products Offered
11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
11.14 Taiyo Nippon Sanso Corporation
11.14.1 Taiyo Nippon Sanso Corporation Corporation Information
11.14.2 Taiyo Nippon Sanso Corporation Description, Business Overview and Total Revenue
11.14.3 Taiyo Nippon Sanso Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Taiyo Nippon Sanso Corporation Products Offered
11.14.5 Taiyo Nippon Sanso Corporation Recent Development
11.15 Urenco Limited
11.15.1 Urenco Limited Corporation Information
11.15.2 Urenco Limited Description, Business Overview and Total Revenue
11.15.3 Urenco Limited Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Urenco Limited Products Offered
11.15.5 Urenco Limited Recent Development
11.16 Rotem Industries, Ltd., Inc.
11.16.1 Rotem Industries, Ltd., Inc. Corporation Information
11.16.2 Rotem Industries, Ltd., Inc. Description, Business Overview and Total Revenue
11.16.3 Rotem Industries, Ltd., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Rotem Industries, Ltd., Inc. Products Offered
11.16.5 Rotem Industries, Ltd., Inc. Recent Development
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Description, Business Overview and Total Revenue
11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Products Offered
11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
11.18 Board of Radiation And Isotope Technology (BRIT)
11.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
11.18.2 Board of Radiation And Isotope Technology (BRIT) Description, Business Overview and Total Revenue
11.18.3 Board of Radiation And Isotope Technology (BRIT) Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Board of Radiation And Isotope Technology (BRIT) Products Offered
11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Description, Business Overview and Total Revenue
11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Products Offered
11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
11.20 Institute of Isotopes Co., Ltd.
11.20.1 Institute of Isotopes Co., Ltd. Corporation Information
11.20.2 Institute of Isotopes Co., Ltd. Description, Business Overview and Total Revenue
11.20.3 Institute of Isotopes Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Institute of Isotopes Co., Ltd. Products Offered
11.20.5 Institute of Isotopes Co., Ltd. Recent Development
11.21 Institute Of Radioelement (IRE)
11.21.1 Institute Of Radioelement (IRE) Corporation Information
11.21.2 Institute Of Radioelement (IRE) Description, Business Overview and Total Revenue
11.21.3 Institute Of Radioelement (IRE) Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Institute Of Radioelement (IRE) Products Offered
11.21.5 Institute Of Radioelement (IRE) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Region
12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.2.2 North America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market Segments
1.3 Key Radiopharmaceuticals in Nuclear Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medicine Industry
1.6.1.1 Radiopharmaceuticals in Nuclear Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2015-2026
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026
2.2 Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020)
3.1.2 Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2019
3.2.5 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (2015-2020)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020)
4.1.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (2015-2020)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2015-2020)
5.1.3 Radiopharmaceuticals in Nuclear Medicine Price by Application (2015-2020)
5.2 Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Radiopharmaceuticals in Nuclear Medicine by Country
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
6.3 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Country
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Region
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Radiopharmaceuticals in Nuclear Medicine by Country
9.1.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
9.1.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
9.3 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Country
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
11.2.2 Cambridge Isotope Laboratories, Inc. Description, Business Overview and Total Revenue
11.2.3 Cambridge Isotope Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Corporation Information
11.3.2 Cardinal Health, Inc. Description, Business Overview and Total Revenue
11.3.3 Cardinal Health, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.3.5 Cardinal Health, Inc. Recent Development
11.4 Covidien, Plc
11.4.1 Covidien, Plc Corporation Information
11.4.2 Covidien, Plc Description, Business Overview and Total Revenue
11.4.3 Covidien, Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
11.4.5 Covidien, Plc Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Corporation Information
11.5.2 Eczacibasi-Monrol Description, Business Overview and Total Revenue
11.5.3 Eczacibasi-Monrol Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Corporation Information
11.6.2 Fujifilm Holdings Corporation Description, Business Overview and Total Revenue
11.6.3 Fujifilm Holdings Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Description, Business Overview and Total Revenue
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Corporation Information
11.8.2 IBA Group Description, Business Overview and Total Revenue
11.8.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
11.8.5 IBA Group Recent Development
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
11.9.2 Isotec, Inc. (Sigma-Aldrich) Description, Business Overview and Total Revenue
11.9.3 Isotec, Inc. (Sigma-Aldrich) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Corporation Information
11.10.2 Lantheus Medical Imaging, Inc. Description, Business Overview and Total Revenue
11.10.3 Lantheus Medical Imaging, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.10.5 Lantheus Medical Imaging, Inc. Recent Development
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.12 Ntp Radioisotopes (Pty), Ltd.
11.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
11.12.2 Ntp Radioisotopes (Pty), Ltd. Description, Business Overview and Total Revenue
11.12.3 Ntp Radioisotopes (Pty), Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ntp Radioisotopes (Pty), Ltd. Products Offered
11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Description, Business Overview and Total Revenue
11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Products Offered
11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
11.14 Taiyo Nippon Sanso Corporation
11.14.1 Taiyo Nippon Sanso Corporation Corporation Information
11.14.2 Taiyo Nippon Sanso Corporation Description, Business Overview and Total Revenue
11.14.3 Taiyo Nippon Sanso Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Taiyo Nippon Sanso Corporation Products Offered
11.14.5 Taiyo Nippon Sanso Corporation Recent Development
11.15 Urenco Limited
11.15.1 Urenco Limited Corporation Information
11.15.2 Urenco Limited Description, Business Overview and Total Revenue
11.15.3 Urenco Limited Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Urenco Limited Products Offered
11.15.5 Urenco Limited Recent Development
11.16 Rotem Industries, Ltd., Inc.
11.16.1 Rotem Industries, Ltd., Inc. Corporation Information
11.16.2 Rotem Industries, Ltd., Inc. Description, Business Overview and Total Revenue
11.16.3 Rotem Industries, Ltd., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Rotem Industries, Ltd., Inc. Products Offered
11.16.5 Rotem Industries, Ltd., Inc. Recent Development
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Description, Business Overview and Total Revenue
11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Products Offered
11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
11.18 Board of Radiation And Isotope Technology (BRIT)
11.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
11.18.2 Board of Radiation And Isotope Technology (BRIT) Description, Business Overview and Total Revenue
11.18.3 Board of Radiation And Isotope Technology (BRIT) Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Board of Radiation And Isotope Technology (BRIT) Products Offered
11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Description, Business Overview and Total Revenue
11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Products Offered
11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
11.20 Institute of Isotopes Co., Ltd.
11.20.1 Institute of Isotopes Co., Ltd. Corporation Information
11.20.2 Institute of Isotopes Co., Ltd. Description, Business Overview and Total Revenue
11.20.3 Institute of Isotopes Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Institute of Isotopes Co., Ltd. Products Offered
11.20.5 Institute of Isotopes Co., Ltd. Recent Development
11.21 Institute Of Radioelement (IRE)
11.21.1 Institute Of Radioelement (IRE) Corporation Information
11.21.2 Institute Of Radioelement (IRE) Description, Business Overview and Total Revenue
11.21.3 Institute Of Radioelement (IRE) Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Institute Of Radioelement (IRE) Products Offered
11.21.5 Institute Of Radioelement (IRE) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Region
12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.2.2 North America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Radiopharmaceuticals in Nuclear Medicine Market Segments
Table 2. Ranking of Global Top Radiopharmaceuticals in Nuclear Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 5. Major Manufacturers of Therapy Radiopharmaceuticals
Table 6. Major Manufacturers of Enriched Stable Isotopes
Table 7. COVID-19 Impact Global Market: (Four Radiopharmaceuticals in Nuclear Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Radiopharmaceuticals in Nuclear Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2015-2020 (K MT)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2015-2020)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2015-2020)
Table 19. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2019)
Table 21. Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2015-2020) (USD/MT)
Table 24. Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 26. Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2015-2020)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2015-2020)
Table 32. Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2015-2020)
Table 35. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 37. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 39. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 41. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 43. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 47. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 49. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 59. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 60. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 64. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 65. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 66. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging S.P.A. Corporation Information
Table 76. Bracco Imaging S.P.A. Description and Major Businesses
Table 77. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bracco Imaging S.P.A. Product
Table 79. Bracco Imaging S.P.A. Recent Development
Table 80. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 81. Cambridge Isotope Laboratories, Inc. Description and Major Businesses
Table 82. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cambridge Isotope Laboratories, Inc. Product
Table 84. Cambridge Isotope Laboratories, Inc. Recent Development
Table 85. Cardinal Health, Inc. Corporation Information
Table 86. Cardinal Health, Inc. Description and Major Businesses
Table 87. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cardinal Health, Inc. Product
Table 89. Cardinal Health, Inc. Recent Development
Table 90. Covidien, Plc Corporation Information
Table 91. Covidien, Plc Description and Major Businesses
Table 92. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Covidien, Plc Product
Table 94. Covidien, Plc Recent Development
Table 95. Eczacibasi-Monrol Corporation Information
Table 96. Eczacibasi-Monrol Description and Major Businesses
Table 97. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eczacibasi-Monrol Product
Table 99. Eczacibasi-Monrol Recent Development
Table 100. Fujifilm Holdings Corporation Corporation Information
Table 101. Fujifilm Holdings Corporation Description and Major Businesses
Table 102. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Fujifilm Holdings Corporation Product
Table 104. Fujifilm Holdings Corporation Recent Development
Table 105. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 106. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 107. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GE Healthcare (Subsidiary Of General Electric Company) Product
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 110. IBA Group Corporation Information
Table 111. IBA Group Description and Major Businesses
Table 112. IBA Group Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. IBA Group Product
Table 114. IBA Group Recent Development
Table 115. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 116. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses
Table 117. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Isotec, Inc. (Sigma-Aldrich) Product
Table 119. Isotec, Inc. (Sigma-Aldrich) Recent Development
Table 120. Lantheus Medical Imaging, Inc. Corporation Information
Table 121. Lantheus Medical Imaging, Inc. Description and Major Businesses
Table 122. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lantheus Medical Imaging, Inc. Product
Table 124. Lantheus Medical Imaging, Inc. Recent Development
Table 125. Nordion, Inc. Corporation Information
Table 126. Nordion, Inc. Description and Major Businesses
Table 127. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Nordion, Inc. Product
Table 129. Nordion, Inc. Recent Development
Table 130. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 131. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses
Table 132. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Ntp Radioisotopes (Pty), Ltd. Product
Table 134. Ntp Radioisotopes (Pty), Ltd. Recent Development
Table 135. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 136. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses
Table 137. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Siemens Healthcare (Subsidiary Of Siemens AG) Product
Table 139. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
Table 140. Taiyo Nippon Sanso Corporation Corporation Information
Table 141. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 142. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Taiyo Nippon Sanso Corporation Product
Table 144. Taiyo Nippon Sanso Corporation Recent Development
Table 145. Urenco Limited Corporation Information
Table 146. Urenco Limited Description and Major Businesses
Table 147. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Urenco Limited Product
Table 149. Urenco Limited Recent Development
Table 150. Rotem Industries, Ltd., Inc. Corporation Information
Table 151. Rotem Industries, Ltd., Inc. Description and Major Businesses
Table 152. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Rotem Industries, Ltd., Inc. Product
Table 154. Rotem Industries, Ltd., Inc. Recent Development
Table 155. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
Table 156. Australian Nuclear Association And Technology Organization (ANSTO) Description and Major Businesses
Table 157. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Australian Nuclear Association And Technology Organization (ANSTO) Product
Table 159. Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
Table 160. Board of Radiation And Isotope Technology (BRIT) Corporation Information
Table 161. Board of Radiation And Isotope Technology (BRIT) Description and Major Businesses
Table 162. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Board of Radiation And Isotope Technology (BRIT) Product
Table 164. Board of Radiation And Isotope Technology (BRIT) Recent Development
Table 165. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
Table 166. Institute of Atomic Energy Polatom Radioisotope Centre Description and Major Businesses
Table 167. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Institute of Atomic Energy Polatom Radioisotope Centre Product
Table 169. Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
Table 170. Institute of Isotopes Co., Ltd. Corporation Information
Table 171. Institute of Isotopes Co., Ltd. Description and Major Businesses
Table 172. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Institute of Isotopes Co., Ltd. Product
Table 174. Institute of Isotopes Co., Ltd. Recent Development
Table 175. Institute Of Radioelement (IRE) Corporation Information
Table 176. Institute Of Radioelement (IRE) Description and Major Businesses
Table 177. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Institute Of Radioelement (IRE) Product
Table 179. Institute Of Radioelement (IRE) Recent Development
Table 180. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions (2021-2026) (K MT)
Table 181. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 182. Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 183. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 184. North America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 185. North America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Europe: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 187. Europe: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 189. Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 190. Latin America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 191. Latin America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 193. Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 194. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 195. Key Challenges
Table 196. Market Risks
Table 197. Main Points Interviewed from Key Radiopharmaceuticals in Nuclear Medicine Players
Table 198. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 199. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
Table 1. Radiopharmaceuticals in Nuclear Medicine Market Segments
Table 2. Ranking of Global Top Radiopharmaceuticals in Nuclear Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 5. Major Manufacturers of Therapy Radiopharmaceuticals
Table 6. Major Manufacturers of Enriched Stable Isotopes
Table 7. COVID-19 Impact Global Market: (Four Radiopharmaceuticals in Nuclear Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Radiopharmaceuticals in Nuclear Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2015-2020 (K MT)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2015-2020)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2015-2020)
Table 19. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2019)
Table 21. Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2015-2020) (USD/MT)
Table 24. Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 26. Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2015-2020)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2015-2020)
Table 32. Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2015-2020)
Table 35. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 37. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 39. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 41. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 43. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 47. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 49. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 59. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 60. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 64. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 65. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 66. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging S.P.A. Corporation Information
Table 76. Bracco Imaging S.P.A. Description and Major Businesses
Table 77. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bracco Imaging S.P.A. Product
Table 79. Bracco Imaging S.P.A. Recent Development
Table 80. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 81. Cambridge Isotope Laboratories, Inc. Description and Major Businesses
Table 82. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cambridge Isotope Laboratories, Inc. Product
Table 84. Cambridge Isotope Laboratories, Inc. Recent Development
Table 85. Cardinal Health, Inc. Corporation Information
Table 86. Cardinal Health, Inc. Description and Major Businesses
Table 87. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cardinal Health, Inc. Product
Table 89. Cardinal Health, Inc. Recent Development
Table 90. Covidien, Plc Corporation Information
Table 91. Covidien, Plc Description and Major Businesses
Table 92. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Covidien, Plc Product
Table 94. Covidien, Plc Recent Development
Table 95. Eczacibasi-Monrol Corporation Information
Table 96. Eczacibasi-Monrol Description and Major Businesses
Table 97. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eczacibasi-Monrol Product
Table 99. Eczacibasi-Monrol Recent Development
Table 100. Fujifilm Holdings Corporation Corporation Information
Table 101. Fujifilm Holdings Corporation Description and Major Businesses
Table 102. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Fujifilm Holdings Corporation Product
Table 104. Fujifilm Holdings Corporation Recent Development
Table 105. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 106. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 107. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GE Healthcare (Subsidiary Of General Electric Company) Product
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 110. IBA Group Corporation Information
Table 111. IBA Group Description and Major Businesses
Table 112. IBA Group Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. IBA Group Product
Table 114. IBA Group Recent Development
Table 115. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 116. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses
Table 117. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Isotec, Inc. (Sigma-Aldrich) Product
Table 119. Isotec, Inc. (Sigma-Aldrich) Recent Development
Table 120. Lantheus Medical Imaging, Inc. Corporation Information
Table 121. Lantheus Medical Imaging, Inc. Description and Major Businesses
Table 122. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lantheus Medical Imaging, Inc. Product
Table 124. Lantheus Medical Imaging, Inc. Recent Development
Table 125. Nordion, Inc. Corporation Information
Table 126. Nordion, Inc. Description and Major Businesses
Table 127. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Nordion, Inc. Product
Table 129. Nordion, Inc. Recent Development
Table 130. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 131. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses
Table 132. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Ntp Radioisotopes (Pty), Ltd. Product
Table 134. Ntp Radioisotopes (Pty), Ltd. Recent Development
Table 135. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 136. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses
Table 137. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Siemens Healthcare (Subsidiary Of Siemens AG) Product
Table 139. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
Table 140. Taiyo Nippon Sanso Corporation Corporation Information
Table 141. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 142. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Taiyo Nippon Sanso Corporation Product
Table 144. Taiyo Nippon Sanso Corporation Recent Development
Table 145. Urenco Limited Corporation Information
Table 146. Urenco Limited Description and Major Businesses
Table 147. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Urenco Limited Product
Table 149. Urenco Limited Recent Development
Table 150. Rotem Industries, Ltd., Inc. Corporation Information
Table 151. Rotem Industries, Ltd., Inc. Description and Major Businesses
Table 152. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Rotem Industries, Ltd., Inc. Product
Table 154. Rotem Industries, Ltd., Inc. Recent Development
Table 155. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
Table 156. Australian Nuclear Association And Technology Organization (ANSTO) Description and Major Businesses
Table 157. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Australian Nuclear Association And Technology Organization (ANSTO) Product
Table 159. Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
Table 160. Board of Radiation And Isotope Technology (BRIT) Corporation Information
Table 161. Board of Radiation And Isotope Technology (BRIT) Description and Major Businesses
Table 162. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Board of Radiation And Isotope Technology (BRIT) Product
Table 164. Board of Radiation And Isotope Technology (BRIT) Recent Development
Table 165. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
Table 166. Institute of Atomic Energy Polatom Radioisotope Centre Description and Major Businesses
Table 167. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Institute of Atomic Energy Polatom Radioisotope Centre Product
Table 169. Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
Table 170. Institute of Isotopes Co., Ltd. Corporation Information
Table 171. Institute of Isotopes Co., Ltd. Description and Major Businesses
Table 172. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Institute of Isotopes Co., Ltd. Product
Table 174. Institute of Isotopes Co., Ltd. Recent Development
Table 175. Institute Of Radioelement (IRE) Corporation Information
Table 176. Institute Of Radioelement (IRE) Description and Major Businesses
Table 177. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Institute Of Radioelement (IRE) Product
Table 179. Institute Of Radioelement (IRE) Recent Development
Table 180. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions (2021-2026) (K MT)
Table 181. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 182. Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 183. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 184. North America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 185. North America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Europe: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 187. Europe: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 189. Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 190. Latin America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 191. Latin America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 193. Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 194. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 195. Key Challenges
Table 196. Market Risks
Table 197. Main Points Interviewed from Key Radiopharmaceuticals in Nuclear Medicine Players
Table 198. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 199. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020 & 2026
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Market Size 2015-2026 (US$ Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026 (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2015-2020)
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2019
Figure 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2015-2020)
Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2019
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2019
Figure 22. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Figure 24. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2019
Figure 25. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2015-2020)
Figure 26. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2019
Figure 27. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Range (2015-2020)
Figure 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Figure 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2019
Figure 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2015-2020)
Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application in 2019
Figure 32. North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 35. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 36. U.S. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 42. Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 46. Germany Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 57. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2019
Figure 62. China Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 85. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 86. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 89. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 90. Mexico Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 97. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 98. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 102. Turkey Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 109. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 110. Bracco Imaging S.P.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cambridge Isotope Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Cardinal Health, Inc. Total Reven
Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020 & 2026
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Market Size 2015-2026 (US$ Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026 (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2015-2020)
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2019
Figure 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2015-2020)
Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2019
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2019
Figure 22. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Figure 24. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2019
Figure 25. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2015-2020)
Figure 26. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2019
Figure 27. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Range (2015-2020)
Figure 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Figure 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2019
Figure 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2015-2020)
Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application in 2019
Figure 32. North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 35. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 36. U.S. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 42. Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 46. Germany Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 57. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2019
Figure 62. China Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 85. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 86. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 89. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 90. Mexico Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 97. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 98. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2019
Figure 102. Turkey Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2019
Figure 109. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2019
Figure 110. Bracco Imaging S.P.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cambridge Isotope Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Cardinal Health, Inc. Total Reven
